Registration for PeproTech.com is no longer available. To order your PeproTech products online, register or logon to ThermoFisher.com.

Resources & Support

References

First Author
Du, Y
Title
Chemokines form nanoparticles with DNA and can superinduce TLR-driven immune inflammation.
Citation
The Journal of experimental medicine; 2022 Jul 4; 219(7)
PubMed ID
35640018
Show Usages
Product Cited
Cross-Reactivity
Applications
300-22
Human
in vitro
300-14
Human
in vitro
300-12
Human
in vitro
300-09
Human
in vitro
300-08
Human
in vitro
300-06
Human
in vitro
300-22
Human
in vitro
300-26
Human
in vitro
300-28A
Human
in vitro
300-29B
Human
in vitro
300-55
Human
in vitro
300-35A
Human
in vitro
250-39
Mouse
in vitro
250-39
Mouse
in vivo
250-39
Mouse
Chemotaxis Assay
250-09
Mouse
Chemotaxis Assay
250-16
Mouse
Chemotaxis Assay
250-20A
Mouse
Chemotaxis Assay
250-07
Mouse
Chemotaxis Assay
250-07
Mouse
in vitro
250-09
Mouse
in vitro
250-16
Mouse
in vitro
250-20A
Mouse
in vitro
First Author
Gurusamy, M
Title
G-protein-coupled receptor P2Y10 facilitates chemokine-induced CD4 T cell migration through autocrine/paracrine mediators.
Citation
Nature communications; 2021 Nov 23; 12(1) pg6798
PubMed ID
34815397
Show Usages
Product Cited
Cross-Reactivity
Applications
200-02
Human
in vitro
300-29B
Human
Chemotaxis Assay
300-35A
Human
Chemotaxis Assay
300-09
Human
Chemotaxis Assay
300-28A
Human
Chemotaxis Assay
300-26
Human
Chemotaxis Assay
300-12
Human
Chemotaxis Assay
300-06
Human
Chemotaxis Assay
First Author
Ofir-Birin, Y
Title
Malaria parasites both repress host CXCL10 and use it as a cue for growth acceleration
Citation
Nature communications; 2021 Aug 11; 12(1) pg4851
PubMed ID
34381047
Show Usages
Product Cited
Cross-Reactivity
Applications
300-12
Human
in vitro
300-06
Human
in vitro
First Author
Wang, W
Title
Stromal induction of BRD4 phosphorylation Results in Chromatin Remodeling and BET inhibitor Resistance in Colorectal Cancer
Citation
Nature communications; 2021 Jul 21; 12(1) pg4441
PubMed ID
34290255
Show Usages
Product Cited
Cross-Reactivity
Applications
200-08
Human
in vitro
300-01A
Human
in vitro
200-01B
Human
in vitro
200-17
Human
in vitro
300-03
Human
in vitro
300-28A
Human
in vitro
250-10
Human
in vitro
300-06
Human
in vitro
250-08
Human
in vitro
First Author
De Groof, T W
Title
Selective targeting of ligand-dependent and -independent signaling by GPCR conformation-specific anti-US28 intrabodies
Citation
Nature communications; 2021 Jul 16; 12(1) pg4357
PubMed ID
34272386
Show Usages
Product Cited
Cross-Reactivity
Applications
300-31
Human
in vitro
300-06
Human
in vitro
900-T10
Human
ELISA
First Author
Wang, Y
Title
SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms
Citation
Scientific reports; 2021 Jan 14; 11(1) pg1399
PubMed ID
33446805
Show Usages
Product Cited
Cross-Reactivity
Applications
300-06
Human
in vitro
200-06
Human
in vitro
First Author
Yacov, N
Title
MOSPD2 is a therapeutic target for the treatment of CNS inflammation.
Citation
Clinical and experimental immunology; 2020 Aug; 201(2) pg105-120
PubMed ID
32353176
Show Usages
Product Cited
Cross-Reactivity
Applications
300-06
Human
in vitro
300-04
Human
in vitro
300-28A
Human
in vitro
210-12
Mouse
in vitro
First Author
Huang, R
Title
CCL5 derived from tumor-associated macrophages promotes prostate cancer stem cells and metastasis via activating β-catenin/STAT3 signaling.
Citation
Cell death & disease; 2020 Apr 16; 11(4) pg234
PubMed ID
32300100
Show Usages
Product Cited
Cross-Reactivity
Applications
300-06
Human
in vitro
First Author
Waldeck, S
Title
CCL5 mediates target-kinase independent resistance to FLT3 inhibitors in FLT3-ITD-positive AML.
Citation
Molecular oncology; 2020 Apr; 14(4) pg779-794
PubMed ID
31955503
Show Usages
Product Cited
Cross-Reactivity
Applications
300-06
Human
in vitro
500-P36
Human
in vitro
900-K33
Human
ELISA
900-M92
Human
ELISA
First Author
Lee, A W
Title
A knottin scaffold directs the CXC-chemokine-binding specificity of tick evasins.
Citation
The Journal of Biological Chemistry;2019 7 19; 294(29) pg11199-11212
PubMed ID
31167786
Show Usages
Product Cited
Cross-Reactivity
Applications
200-02
Human
in vitro
300-37
Human
Chemotaxis Assay
300-04
Human
Chemotaxis Assay
300-08
Human
Chemotaxis Assay
300-56
Human
Chemotaxis Assay
300-09
Human
Chemotaxis Assay
300-58
Human
Chemotaxis Assay
300-06
Human
Chemotaxis Assay
300-17
Human
Chemotaxis Assay
300-15
Human
Chemotaxis Assay
300-21
Human
Chemotaxis Assay
300-24
Human
Chemotaxis Assay
300-38
Human
Chemotaxis Assay
300-43
Human
Chemotaxis Assay
300-44
Human
Chemotaxis Assay
300-30
Human
Chemotaxis Assay
300-34
Human
Chemotaxis Assay
300-29B
Human
Chemotaxis Assay
300-29A
Human
Chemotaxis Assay
300-35
Human
Chemotaxis Assay
300-36A
Human
Chemotaxis Assay
300-29
Human
Chemotaxis Assay
300-33
Human
Chemotaxis Assay
300-48
Human
Chemotaxis Assay
300-54
Human
Chemotaxis Assay
300-11
Human
Chemotaxis Assay
300-39
Human
Chemotaxis Assay
300-40
Human
Chemotaxis Assay
300-16
Human
Chemotaxis Assay
300-22
Human
Chemotaxis Assay
300-22B
Human
Chemotaxis Assay
300-41
Human
Chemotaxis Assay
300-14
Human
Chemotaxis Assay
200-08
Human
Chemotaxis Assay
300-26
Human
Chemotaxis Assay
300-12
Human
Chemotaxis Assay
300-46
Human
Chemotaxis Assay
300-28A
Human
Chemotaxis Assay
300-28B
Human
Chemotaxis Assay
300-47
Human
Chemotaxis Assay
300-50
Human
Chemotaxis Assay
300-55
Human
Chemotaxis Assay
300-31
Human
Chemotaxis Assay
showing 10 of 144
Show More